The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would drugmakers agree to reduce their prices right away?

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Metsera seeks to raise up to $292.2 million in US IPO Venture capital firm ARCH Ventures founded Metsera in 2022 Jan 27 (Reuters) - Metsera, which is developing weight-loss drugs, said on Monday ...

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Jan 17 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said a higher dose of its drug Wegovy led to greater weight loss in patients ... that were released in 2022 showed patients taking a ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic ... 5.3 million people with Medicare prescription drug coverage used these medications ...

Diabetes and weight loss drugs Ozempic and Wegovy ... 65 or older to negotiate the price of certain drugs with the companies that make them — was instituted following the Inflation Reduction Act of ...

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.